AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33118702 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% chitosan supplementation
Number of subjects: 80
Study 32634275 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 3981
Study 32634275 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 3981
Study 32634275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3981
Study 35793983 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic impression lining material (DIL)
Number of subjects: 25
Study 35793983 — intervention group
Group type: COMPARATOR
Intervention: Conventional hard denture liner (HL)
Number of subjects: 25
Study 34246121 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 398
Study 32419349 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 49
Study 32419349 — intervention group
Group type: COMPARATOR
Intervention: Non-Foley catheter
Number of subjects: 49
Study 34954840 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 391
Study 34954840 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 391
Study 35702007 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal capacitive-resistive monopolar radiofrequency plus exercising
Number of subjects: 81
Study 33522019 — intervention group
Group type: EXPERIMENTAL
Intervention: IV and local tranexamic acid (TA)
Number of subjects: 120
Study 33522019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33522019 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 32851921 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous neuromuscular blockade (NMB) for 24 hours
Number of subjects: 80
Study 32851921 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study 32851921 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous neuromuscular blockade (NMB)
Number of subjects: 80
Study 35062899 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology (10 min of general massage and specific reflexology on uterine, pituitary, and solar plexus points)
Number of subjects: 80
Study 35062899 — intervention group
Group type: COMPARATOR
Intervention: General massage (10 min) on a neutral point on the lateral side of the heel
Number of subjects: 80
Study 34373301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose
Number of subjects: 84
Study 34373301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 33926288 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent reading intervention (MCRI)
Number of subjects: 128
Study 33926288 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 128
Study 32131077 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone overdependence prevention program (8 sessions, twice a week)
Number of subjects: 64
Study 35237700 — intervention group
Group type: EXPERIMENTAL
Intervention: D/C/F/TAF
Number of subjects: 306
Study 35237700 — intervention group
Group type: COMPARATOR
Intervention: DTG/3TC/ABC
Number of subjects: 306
Study 33870919 — intervention group
Group type: EXPERIMENTAL
Intervention: Earplugs and eye masks in addition to standard postoperative care
Number of subjects: 0
Study 33870919 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 0
Study 33914158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injections (3 monthly injections followed by treat-and-extend regimen)
Number of subjects: 48
Study 33788599 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Center Trauma‐Sensitive Yoga (TCTSY); n=58, 10 weekly 60-min group sessions.
Number of subjects: 104
Study 33788599 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT); n=46, 12 weekly 90-min group sessions.
Number of subjects: 104
Study 35973009 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy
Number of subjects: 0
Study 35973009 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment strategy
Number of subjects: 0
Study 35973009 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 MI
Number of subjects: 0
Study 35973009 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural MI (primary definition)
Number of subjects: 0
Study 35973009 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural MI (secondary definition)
Number of subjects: 0
Study 35398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 0
Study 35398549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33663939 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Saline Bladder Irrigation (CSBI)
Number of subjects: 167
Study 33663939 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CSBI)
Number of subjects: 167
Study 33663939 — intervention group
Group type: EXPERIMENTAL
Intervention: CSBI
Number of subjects: 167
Study 33663939 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin (MMC)
Number of subjects: 167
Study 35589025 — intervention group
Group type: EXPERIMENTAL
Intervention: Bring BG Down! intervention group (telehealth sessions for 6 months)
Number of subjects: 0
Study 35589025 — intervention group
Group type: COMPARATOR
Intervention: Control group (only completed questionnaires)
Number of subjects: 0
Study 33663059 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Liujunzi Decoction
Number of subjects: 0
Study 33663059 — intervention group
Group type: COMPARATOR
Intervention: Liujunzi Decoction
Number of subjects: 0
Study 34847780 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (AG)
Number of subjects: 171
Study 34847780 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 171
Study 32387523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygenation/ventilation strategies
Number of subjects: 74
Study 32387523 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized management of ARF
Number of subjects: 74
Study 32387523 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically based primary end points
Number of subjects: 74
Study 32387523 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐center trials
Number of subjects: 74
Study 36328403 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation alone
Number of subjects: 120
Study 36328403 — intervention group
Group type: COMPARATOR
Intervention: Delayed ACLR
Number of subjects: 120
Study 36328403 — intervention group
Group type: COMPARATOR
Intervention: Early ACLR
Number of subjects: 120
Study 36328403 — intervention group
Group type: EXPERIMENTAL
Intervention: Healed ACL group
Number of subjects: 120
Study 36328403 — intervention group
Group type: COMPARATOR
Intervention: Non-healed group
Number of subjects: 120
Study 34391294 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates protocol for 8 weeks, 2 sessions per week
Number of subjects: 44
Study 32050951 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail reminder
Number of subjects: 240
Study 32050951 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminder
Number of subjects: 240
Study 32050951 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined mail and telephone reminders
Number of subjects: 240
Study 32050951 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual postcards)
Number of subjects: 240
Study 34172103 — intervention group
Group type: EXPERIMENTAL
Intervention: Dignity therapy (DT)
Number of subjects: 39
Study 34091572 — intervention group
Group type: EXPERIMENTAL
Intervention: PERN's collaborative research efforts
Number of subjects: 0
Study 34091572 — intervention group
Group type: EXPERIMENTAL
Intervention: PERN's global randomized controlled trials
Number of subjects: 0
Study 34091572 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective observational studies
Number of subjects: 0
Study 34091572 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus on implementation science
Number of subjects: 0
Study 34091572 — intervention group
Group type: EXPERIMENTAL
Intervention: Expansion of PERN's global reach
Number of subjects: 0
Study 32966971 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide plus insulin glargine
Number of subjects: 92
Study 32966971 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro plus glargine
Number of subjects: 92
Study 33124189 — intervention group
Group type: EXPERIMENTAL
Intervention: 360° argon or selective laser trabeculoplasty (LTP)
Number of subjects: 122
Study 32576561 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with exenatide (2 mg/week) and pioglitazone (30 mg/day)
Number of subjects: 38
Study 32576561 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal-bolus insulin (glargine with aspart)
Number of subjects: 38
Study 32576561 — intervention group
Group type: COMPARATOR
Intervention: Control group (baseline only)
Number of subjects: 38
Study 36180899 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-life conversation game (Hello)
Number of subjects: 1500
Study 36180899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nationally utilized workshop format for ACP conversations (The Conversation Project)
Number of subjects: 1500
Study 36180899 — intervention group
Group type: COMPARATOR
Intervention: Attention control game (TableTopics)
Number of subjects: 1500
Study 36180899 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 1500
Study 34103002 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during metronome-assisted walking at 84 steps per minute
Number of subjects: 15
Study 34103002 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during metronome-assisted walking at 100 steps per minute
Number of subjects: 15
Study 34103002 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during the 200-m walk
Number of subjects: 15
Study 34103002 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during walking at 84 and 100 steps per minute, and stepping-in-place at 100 steps per minute
Number of subjects: 15
Study 36056908 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided capsular injection of dexamethasone (DEX) and lidocaine
Number of subjects: 73
Study 36056908 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (PSL)
Number of subjects: 73
Study 32050090 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated surgery
Number of subjects: 2970
Study 32050090 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 2970
Study 33579718 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate insertion of the copper IUD (within 24 hours)
Number of subjects: 114
Study 33579718 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of the copper IUD (3 weeks post-abortion)
Number of subjects: 114
Study 33579718 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate insertion of the copper IUD
Number of subjects: 114
Study 33579718 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of the copper IUD
Number of subjects: 114
Study 33624848 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-based cognitive-behavioral therapy (CBT)
Number of subjects: 124
Study 33624848 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based SPACE (Supportive Parenting for Anxious Childhood Emotions)
Number of subjects: 124
Study 35471254 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated nomogram incorporating age, rT-stage, and deep learning PET/CT signature
Number of subjects: 420
Study 35471254 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated nomogram
Number of subjects: 420
Study 35471254 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk patients
Number of subjects: 420
Study 35471254 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk patients
Number of subjects: 420
Study 33160256 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational board game intervention
Number of subjects: 259
Study 33160256 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 259
Study 35388730 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 195
Study 34258935 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct stimulation followed by yoga intervention
Number of subjects: 22
Study 34258935 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct stimulation followed by yoga intervention
Number of subjects: 22
Study 34258935 — intervention group
Group type: COMPARATOR
Intervention: Both active and sham transcranial direct stimulation
Number of subjects: 22
Study 34258935 — intervention group
Group type: COMPARATOR
Intervention: Active vs. Sham transcranial direct stimulation
Number of subjects: 22
Study 32451909 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg every 2 weeks
Number of subjects: 0
Study 32451909 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab 150 mg every 2 weeks
Number of subjects: 0
Study 34287622 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy (CBGT)
Number of subjects: 108
Study 34287622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 108
Study 34287622 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 108
Study 32500299 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component exercise program (high-intensity progressive resistance training at 60-85% max, weight-bearing impact exercise, 3 days/week for 18 months)
Number of subjects: 180
Study 32500299 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component exercise program
Number of subjects: 180
Study 32500299 — intervention group
Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 180
Study 32500299 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component exercise program and No exercise
Number of subjects: 180
Study 32838647 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg
Number of subjects: 184
Study 32838647 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 400 mg
Number of subjects: 184
Study 32838647 — intervention group
Group type: EXPERIMENTAL
Intervention: standard dose regimen (tenofovir disoproxil 200 mg, efavirenz 600 mg and lamivudine)
Number of subjects: 184
Study 32838647 — intervention group
Group type: COMPARATOR
Intervention: lower dose regimen (tenofovir disoproxil 200 mg, efavirenz 400 mg and lamivudine)
Number of subjects: 184
Study 35254032 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 0
Study 35254032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34544660 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training (written materials plus live training with coaching and active monitoring)
Number of subjects: 50
Study 34544660 — intervention group
Group type: COMPARATOR
Intervention: Minimal training (written materials only)
Number of subjects: 50
Study 34544660 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training
Number of subjects: 50
Study 34544660 — intervention group
Group type: COMPARATOR
Intervention: Minimal training
Number of subjects: 50
Study 33760866 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV test (OncoE6TM Cervical Test) specific to HPV16/18 in cervical swabs
Number of subjects: 337
Study 33760866 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA)
Number of subjects: 337
Study 33760866 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 337
Study 33760866 — intervention group
Group type: EXPERIMENTAL
Intervention: History of sexually transmitted illnesses (STIs)
Number of subjects: 337
Study 33250384 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz repetitive TMS (rTMS) to the left DLPFC (110% resting motor threshold)
Number of subjects: 22
Study 33250384 — intervention group
Group type: COMPARATOR
Intervention: 10 Hz repetitive TMS (rTMS) to the left MC (90% resting motor threshold)
Number of subjects: 22
Study 32303894 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT (14-week face-to-face group intervention)
Number of subjects: 145
Study 32303894 — intervention group
Group type: COMPARATOR
Intervention: Control group (services as usual)
Number of subjects: 145
Study 34929030 — intervention group
Group type: EXPERIMENTAL
Intervention: M. tuberculosis-specific CD4+ cytokine responses during late pregnancy (third trimester)
Number of subjects: 49
Study 34929030 — intervention group
Group type: EXPERIMENTAL
Intervention: M. tuberculosis-specific CD8+ cytokines
Number of subjects: 49
Study 34929030 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspecific T-cell activation
Number of subjects: 49
Study 33583728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 14
Study 33583728 — intervention group
Group type: COMPARATOR
Intervention: Blind technique
Number of subjects: 14
Study 34147014 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC)
Number of subjects: 160
Study 34147014 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) pertuzumab and trastuzumab
Number of subjects: 160
Study 34147014 — intervention group
Group type: EXPERIMENTAL
Intervention: PH FDC SC continuation
Number of subjects: 160
Study 34147014 — intervention group
Group type: COMPARATOR
Intervention: Patient treatment room time
Number of subjects: 160
Study 34147014 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 160
Study 33225961 — intervention group
Group type: COMPARATOR
Intervention: Standard fortification (HMF, Nutricia)
Number of subjects: 0
Study 33225961 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted fortification (modular components: Bebilon Bialka, Nutricia—protein; Polycal, Nutricia—carbohydrates; Calogen, Nutricia—lipids)
Number of subjects: 0
Study 35018561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (smoking cessation coaching, nicotine replacement therapy, money management coaching, referral to financial benefits and empowerment services)
Number of subjects: 410
Study 35018561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 410
Study 35018561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention among medical center participants
Number of subjects: 410
Study 35018561 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care during a 6-month waiting period)
Number of subjects: 410
Study 33430250 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning-BRJ (8:00 HR)
Number of subjects: 10
Study 33430250 — intervention group
Group type: COMPARATOR
Intervention: Morning-placebo (8:00 HR)
Number of subjects: 10
Study 35668499 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) kits distributed by trained promotors
Number of subjects: 0
Study 35668499 — intervention group
Group type: COMPARATOR
Intervention: Vouchers for free HIVST at nearby clinics distributed by control promotors
Number of subjects: 0
Study 35668499 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of 6- and 12-month viral load in those living with HIV
Number of subjects: 0
Study 35668499 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of PrEP adherence via urine tenofovir levels among those without HIV
Number of subjects: 0
Study 32698860 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated ventilation (AV) using INTELLiVENT‐ASV®
Number of subjects: 265
Study 32698860 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated ventilation (AV)
Number of subjects: 265
Study 32698860 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 265
Study 33656939 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Dot bystander intervention
Number of subjects: 0
Study 33656939 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34135084 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization methods applied to investigate causal relationships of risk factors with kidney function or CKD.
Number of subjects: 0
Study 32402496 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied in osteotomy sites after fixation
Number of subjects: 44
Study 32402496 — intervention group
Group type: COMPARATOR
Intervention: No PRF (control group)
Number of subjects: 44
Study 32876962 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequent low dosage IVIg treatment (half individual dose at half the interval)
Number of subjects: 25
Study 32876962 — intervention group
Group type: COMPARATOR
Intervention: Low frequent high dosage IVIg treatment (individual IVIg dose and interval)
Number of subjects: 25
Study 32876962 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequent low dosage IVIg treatment
Number of subjects: 25
Study 32876962 — intervention group
Group type: COMPARATOR
Intervention: Low frequent high dosage IVIg treatment
Number of subjects: 25
Study 32508341 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward treadmill training (BTT)
Number of subjects: 18
Study 32508341 — intervention group
Group type: COMPARATOR
Intervention: Standard forward treadmill training (FTT)
Number of subjects: 18
Study 35698074 — intervention group
Group type: EXPERIMENTAL
Intervention: MultiPill-Exercise
Number of subjects: 320
Study 35698074 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 320
Study 34470492 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection
Number of subjects: 36
Study 34470492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 35759320 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-effort recruitment strategies (both mass and direct)
Number of subjects: 457
Study 35759320 — intervention group
Group type: COMPARATOR
Intervention: Direct, high-effort recruitment strategies
Number of subjects: 457
Study 35759320 — intervention group
Group type: COMPARATOR
Intervention: Mass recruitment strategies
Number of subjects: 457
Study 33019892 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention over 8 weeks
Number of subjects: 259